Details of the Drug-Related molecule(s) Interaction Atlas

US9656955, Example 351 Drug Info

SCHEMBL16032164; BDBM308837; US9656955, Example 351; N-{(3R,4S)-4-(4-fluorophenyl)-1-[(1-methyl-1H-imidazol-4-yl)sulfonyl]pyrrolidin-3-yl}-6-(trifluoromethyl)pyridin-2-amine

Cross-matching ID

PubChem CID

86295652

TTD Drug ID

DMXU8DI

General Information of Drug (ID: DMXU8DI)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting N-acetylglucosaminyltransferase I (NAGAT1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US9656955, Example 652	DMKS7D9	N. A.	N. A.	Patented	[1]
US9586945, 1	DM2RE91	N. A.	N. A.	Patented	[2]
US9586945, 19a	DMKZC4V	N. A.	N. A.	Patented	[2]
US9586942, 2	DMZ745J	N. A.	N. A.	Patented	[3]
US9656955, Example 540	DMC3Q9O	N. A.	N. A.	Patented	[1]
US9586942, 16	DMERWUQ	N. A.	N. A.	Patented	[3]
US9586942, 3*	DMRXCYF	N. A.	N. A.	Patented	[3]
US9586945, 5	DM6A8XJ	N. A.	N. A.	Patented	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
N-acetylglucosaminyltransferase I (NAGAT1)	TTYJRN5	MGAT1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy. US9656955.
2	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586945.
3	Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586942.